Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Norris

Showing results (741-750 of 885) with videos related to

Pageof 89
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infectionSandra Lopez-Vergès, Jeffrey M Milush, Brian S Schwartz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2012
Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatmentRobert C Kaplan, Alan L Landay, Howard N Hodis, et al.
AIDS (London, England)|July 24, 2010
Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individualsHiroyu Hatano, Eric L Delwart, Philip J Norris, et al.
The Journal of Infectious Diseases|August 30, 2008
Virus and antibody dynamics in acute west nile virus infectionMichael P Busch, Steven H Kleinman, Leslie H Tobler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolonesKwanghee Kim, Julianne M Pollard, Andrew J Norris, et al.
Molecular Immunology|October 12, 2005
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitopePhilip J Norris, Jennifer D Stone, Nadezhda Anikeeva, et al.
AIDS (London, England)|February 26, 2013
Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV studyChristina M Parrinello, Alan L Landay, Howard N Hodis, et al.
Atherosclerosis|October 24, 2012
Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV studyChristina M Parrinello, Alan L Landay, Howard N Hodis, et al.
Hemasphere|January 12, 2026
Hypomorphic <i>ATP11c</i> is a novel regulator of decreased efficacy of transfused red blood cells in humans and miceJames C Zimring, Ariel M Hay, Monika Dzieciatkowska, et al.
Transfusion|March 23, 2016
The effects of 22°C and 4°C storage of platelets on vascular endothelial integrity and functionGyulnar Baimukanova, Byron Miyazawa, Daniel R Potter, et al.
Pageof 89

Showing results (741-750 of 885) with videos related to

Sort By:
Pageof 89
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infectionSandra Lopez-Vergès, Jeffrey M Milush, Brian S Schwartz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2012
Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatmentRobert C Kaplan, Alan L Landay, Howard N Hodis, et al.
AIDS (London, England)|July 24, 2010
Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individualsHiroyu Hatano, Eric L Delwart, Philip J Norris, et al.
The Journal of Infectious Diseases|August 30, 2008
Virus and antibody dynamics in acute west nile virus infectionMichael P Busch, Steven H Kleinman, Leslie H Tobler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolonesKwanghee Kim, Julianne M Pollard, Andrew J Norris, et al.
Molecular Immunology|October 12, 2005
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitopePhilip J Norris, Jennifer D Stone, Nadezhda Anikeeva, et al.
AIDS (London, England)|February 26, 2013
Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV studyChristina M Parrinello, Alan L Landay, Howard N Hodis, et al.
Atherosclerosis|October 24, 2012
Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV studyChristina M Parrinello, Alan L Landay, Howard N Hodis, et al.
Hemasphere|January 12, 2026
Hypomorphic <i>ATP11c</i> is a novel regulator of decreased efficacy of transfused red blood cells in humans and miceJames C Zimring, Ariel M Hay, Monika Dzieciatkowska, et al.
Transfusion|March 23, 2016
The effects of 22°C and 4°C storage of platelets on vascular endothelial integrity and functionGyulnar Baimukanova, Byron Miyazawa, Daniel R Potter, et al.
Pageof 89